Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arcutis Biotherapeutics Inc (ARQT)

Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour

ARQT : 10.60 (+4.13%)
Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update

ARQT : 10.60 (+4.13%)
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ARQT : 10.60 (+4.13%)
Arcutis Presents Positive Patient-Reported Outcome Data for ZORYVE® (Roflumilast) Cream 0.15% in Atopic Dermatitis at American College of Allergy, Asthma and Immunology 2024 Annual Scientific Meeting

ARQT : 10.60 (+4.13%)
Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference

ARQT : 10.60 (+4.13%)
Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older

ARQT : 10.60 (+4.13%)
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ARQT : 10.60 (+4.13%)
3 'Strong-Buy'-Rated Russell 2000 Stocks With 54% to 110% Upside

Investing in these small caps could be rewarding in the long run.

VKTX : 53.68 (+4.17%)
ARQT : 10.60 (+4.13%)
LBPH : 59.76 (-0.02%)
$SPX : 5,954.14 (+0.63%)
5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

JANX : 47.89 (-2.19%)
VKTX : 53.68 (+4.17%)
LBPH : 59.76 (-0.02%)
ARQT : 10.60 (+4.13%)
RNA : 43.79 (+0.32%)
S&P Futures Higher After April CPI is Released

June S&P 500 E-Mini futures (ESM24) are trending up +0.45% this morning after April's CPI report was released.

ESM24 : 5,471.89s (-0.09%)
SMCI : 29.71 (+15.16%)
ORCL : 195.89 (+2.69%)
SCHW : 81.36 (+1.12%)
PARA : 10.93 (+3.31%)
CSCO : 57.67 (+0.30%)
GRAB : 5.66 (-0.27%)
MNDY : 276.35 (+6.23%)
EXPN.LN : 3,710.000 (+2.18%)
MRK.D.DX : 138.300 (-0.13%)
NESTE.H.DX : 14.215 (+1.64%)
ARQT : 10.60 (+4.13%)

Barchart Exclusives

ELF’s Unusual Options Activity Is a Thing of Questionable Beauty
E.L.F. Beauty’s options volume on Wednesday was 7x the 30-day average. The affordable makeup and skincare company’s unusual options activity stood out as one investor questioned its revenues. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar